5
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Augmented antitumour effects of combined treatment with hyperthermia and tumour necrosis factor on human gastric cancer xenotransplanted into nude mice

, , , , , , , & show all
Pages 511-518 | Received 09 Jul 1990, Accepted 12 Sep 1990, Published online: 09 Jul 2009

References

  • Asami T., Imai M., Tanaka Y., Hosaka Y., Kato K., Nakamura N., Horisawa Y., Ashida Y., Kanamori T., Nobuhara M., Kurimoto M. In vivo antitumor mechanism of natural human tumor necrosis factor involving a T cell-mediated immunologic route. Japanese Journal of Cancer Research 1989; 80: 1161–1164
  • Aukland K., Bower B. F., Berliner R. W. Measurement of local blood flow with hydrogen gas. Circulation Research 1964; 14: 164–187
  • Balkwill F. R., Lee A., Aldam G., Moodie E., Thomas J. A., Tavernier J., Fier W. Human tumor xenografts treated with recombinant human tumor necrosis factor alone or in combination with interferons. Cancer Research 1986; 46: 3990–3993
  • Balkwill F. R., Ward B. G., Moodie E., Fiers W. Therapeutic potential of tumor necrosis factor alpha and gamma interferon in experimental human ovarian cancer. Cancer Research 1987; 47: 4755–4758
  • Bicher H. I., Hetzel F. W., Sandhu T. S., Frinak S., Vaupel P., O'Hara M. D., O'Brien T. Effects of hyperthermia on normal and tumor microenvironment. Radiology 1980; 137: 523–530
  • Carswell E. A., Old L. J., Kassel R. L., Green S., Fiore N., Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proceedings of the National Academy of Sciences, USA 1975; 72: 3666–3670
  • Chun M., Hoffmann M. K. Combination immunotherapy of cancer in a mouse model: synergism between tumor necrosis factor and other defense systems. Cancer Research 1987; 47: 115–118
  • Creasey A. A., Doyle L. V., Reynolds M. T., Jung T., Lin L. S., Vitt C. R. Biological effects of recombinant human tumor necrosis factor and its novel muteins on tumor and normal cell lines. Cancer Research 1987; 47: 145–149
  • Dudar T. E., Jain R. K. Differential response of normal and tumor microcirculation to hyperthermia. Cancer Research 1984; 44: 605–612
  • Fujimoto S., Shrestha R. D., Kokubun M., Ohta M., Takahashi M., Kobayashi K., Kiuchi S., Okui K. Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding. Annals of Surgery 1988a; 208: 36–41
  • Fujimoto S., Ohta M., Shrestha R. D., Kokubun M., Miyoshi T., MoM T., Okui K. Enhancement of hyperthermochemotherapy for human gastric cancer in nude mice by thermosensitization with nitroimidazoles. British Journal of Cancer 1988b; 58: 42–45
  • Fujimoto S., Ohta M., Shrestha R. D., Kokubun M., Kobayashi K., Kiuchi S., Konno C., Takahashi M., Fujita M., Taguchi T., Okui K. Thermotolerance of xenografted human gastric cancer. Japanese Journal of Surgery 1989; 19: 203–207
  • Helson L., Green S., Carswell E. A., Old L. J. Effect of tumor necrosis factor on cultured human melanoma cells. Nature 1975; 258: 731–732
  • Kokubun M., Fujimoto S., Shrestha R. D., Ohta M., Kobayashi K., Kiuchi S., Fujita M., Taguchi T., Okui K. Relationship between thermotolerance and tissue oxygen tension in human gastric cancer transplanted to nude mice. Abstract of the 5th International Symposium on Hyperthemic Oncology, T. Sugawara, M. Saito. Taylor & Francis, London, New York, Philadelphia 1989; 94–96
  • Kull F. C., Jr, Cuatrecasas P. Possible requirement of internalization in the mechanism of in vitro cytotoxicity in tumor necrosis serum. Cancer Research 1981; 41: 4885–4890
  • Matthews N., Watkins J. F. Tumor necrosis factor from the rabbit. I. Mode of action, specificity and physicochemical properties. British Journal of Cancer 1978; 38: 302–309
  • Nawroth P. P., Stern D. M. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. Journal of Experimental Medicine 1986; 163: 740–745
  • Regenass V., Muller M., Curschellas E., Matter A. Antitumor effects of tumor necrosis factor in combination with chemotherapeutic agents. International Journal of Cancer 1987; 39: 266–273
  • Ruff M. R., Gifford G. E. Rabbit tumor necrosis factor: mechanism of action. Infection and Immunity 1981; 31: 380–385
  • Schirmer W. J., Schirmer J. M., Fry D. E. Recombinant human tumor necrosis factor produces hemodynamic changes characteristic of sepsis and endotoxemia. Archives of Surgery 1989; 124: 445–448
  • Shine N., Palladin M. A., Jr, Patton J. s., Deisseroth A., Karczmar G. s., Matson G. B., Weiner M. W. Early metabolic response to tumor necrosis factor in mouse sarcoma: A phosphorus-31 nuclear magnetic resonance study. Cancer Research 1989; 49: 2123–2137
  • Song C. W. Effect of local hyperthermia on blood flow and microenvironment. Cancer Research 1984; 44: 4721s–4730s
  • Sugarman B. J., Aggarwal B. B., Hass P. E., Figari I. S., Palladino M. A., Shepard H. M. Recombinant human tumor necrosis factor-α: effects on proliferation of normal and transformed cells. in vitro. Science 1985; 230: 943–945
  • Tagchi T. A Phase I study of recombinant human tumor necrosis factor (rH-TNF:PT-050). Jupanese Journal of Cancer Chemotherapy 1986; 13: 3491–3497
  • Tracy K. J., Beutler B., Lowry S. F., Merryweather J., Wolpe S., Milsark I. W., Hariri R. J., Fahey T. J., III, Zentella A., Albert J. D., Shires T., Ceraml A. Shock and tissue injury induced by recombinant human cachectin. Science 1986; 234: 470–474
  • Tracey K. J., Lowry S. F., Fahey T. J., III, Albert J. D., Fong Y., Hesse D., Beutler B., Manogue K. R., Calvano S., Wei H., Cerami A., Shires G. T. Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog. Surgery, Gynecology and Obstetrics 1087; 164: 415–422
  • Watanabe N., Niitsu Y., Sonne H., Neda H., Yamauchi N., Umetsu T., Urushizaki I. Antitumor effect of tumor necrosis factor against various primarily cultured human cancer cells. Japanese Journal of Cancer Research 1985; 76: 1115–1119
  • Watanabe N., Neda H., Ohtsuka Y., Sonne H., Yamauchi N., Umetsu T., Niitsu Y., Urushizaki I. Analysis of the signalling pathway of TNF in normal cells and tumor cells. Japanese Journal of Cancer Chemotherapy 1987; 14: 611–617
  • Watanabe N., Niitsu Y., Umeno H., Sonne H., Neda H., Yamauchi N., Maeda M., Urushizaki I. Synergistic cytotoxic and antitumor effects of recombinant human tumor necrosis factor and hyperthermia. Cancer Research 1988a; 48: 650–653
  • Watanabe N., Niitsu Y., Umeno H., Kuriyama H., Neda H., Yamauchi N., Maeda M., Urushizaki I. Toxic effect of tumor necrosis factor on tumor vasculature in mice. Cancer Research 1988b; 48: 2179–2183
  • Wiliamson B. D., Carswell E. A., Rubin B. Y., Prendergast J. S., Old L. J. Human tumor necrosis factor produced by human B-cell lines: synergistic cytotoxic interaction with human interferon. Proceedings of the National Academy of Sciences, USA 1983; 80: 5397–5401
  • Winkelhake J. L., Stampfl S., Zimmerman R. J. Synergistic effects of combination therapy with human recombinant interleukin 2 and tumor necrosis factor in murine tumor models. Cancer Research 1987; 47: 3948–3953
  • Yamazaki S., Onishi E., Enami K., Natori K., Kohase M., Sakamoto H., Tonouchi M., Hayashi H. Proposal of standardized methods and reference for assaying recombinant human tumor necrosis factor. Japanese Journal of Medical Science and Biology 1986; 39: 105–118
  • Zierler K. L. Equations for measuring blood flow by external monitoring of radioisotopes. Circulation Research 1965; 16: 309–321

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.